StockData
Vogenx, Inc. logo

Vogenx, Inc. (VOGX) stock

VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$13.48−0.90 (-6.26%)

Close on Nov 17, 2026Market cap $200.25MP/E –Yield –

Vogenx EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Vogenx

Vogenx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vogenx figures

See a number that looks wrong?